Cargando…

Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression

Spleen tyrosine kinase (SYK) has been reported as a potential tumor suppressor in colorectal cancer (CRC). However, the role of alternative splicing of SYK in carcinogenesis remains unclear. In the present study, SYK isoforms were overexpressed in the human CRC HCT 116 cell line using lentiviral exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Beibei, Hu, Jun, Chen, Dianke, Li, Li, Chen, Daici, Wang, Jianping, Wang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998349/ https://www.ncbi.nlm.nih.gov/pubmed/27602108 http://dx.doi.org/10.3892/ol.2016.4858

Ejemplares similares

Prognostic value of spleen tyrosine kinase in human solid tumors
por: Ni, Beibei, et al.
Publicado: (2018)

Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells
por: Denis, Vincent, et al.
Publicado: (2022)

Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014)

KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report
por: Luo, Qianxin, et al.
Publicado: (2020)

Role of spleen tyrosine kinase in liver diseases
por: Kurniawan, Dhadhang Wahyu, et al.
Publicado: (2020)

Exploration of Alternative Splicing (AS) Events in MDV-Infected Chicken Spleens
por: Wang, Lulu, et al.
Publicado: (2021)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
por: Li, Mohan, et al.
Publicado: (2023)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
por: Zhou, Yaqi, et al.
Publicado: (2023)

Spleen Tyrosine Kinase Inhibition Modulates p53 Activity
por: Althubiti, Mohammad
Publicado: (2017)

An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis
por: Han, Yingjie, et al.
Publicado: (2018)

Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
por: Schweig, Jonas Elias, et al.
Publicado: (2017)

CD11b promotes the differentiation of osteoclasts induced by RANKL through the spleen tyrosine kinase signalling pathway
por: Yang, Guoxi, et al.
Publicado: (2017)

Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma
por: Liu, Qian, et al.
Publicado: (2022)

The Expression and Clinical Significance of Spleen Tyrosine Kinase in Patients with Coronary Heart Disease
por: Liang, Ke, et al.
Publicado: (2019)

GLTSCR1 coordinates alternative splicing and transcription elongation of ZO1 to regulate colorectal cancer progression
por: Han, Fengyan, et al.
Publicado: (2022)

The novel long noncoding RNA u50535 promotes colorectal cancer growth and metastasis by regulating CCL20
por: Yu, Xihu, et al.
Publicado: (2018)

Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases
por: Pamuk, Omer N, et al.
Publicado: (2010)

Spleen Tyrosine Kinase Mediates Microglial Activation in Mice With Diabetic Retinopathy
por: Liu, Xiaozhe, et al.
Publicado: (2021)

Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19
por: Wigerblad, Gustaf, et al.
Publicado: (2023)

The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases
por: Zhao, Yaping, et al.
Publicado: (2022)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
por: Muro, Ryunosuke, et al.
Publicado: (2023)

Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection
por: Ullah, Imran, et al.
Publicado: (2023)

Spleen tyrosine kinase expression and its correlation with necrosis and high-risk histopathologic features in retinoblastoma
por: Yang, Ya-Li, et al.
Publicado: (2020)

Phosphorylation impact on Spleen Tyrosine kinase conformation by Surface Enhanced Raman Spectroscopy
por: Cottat, Maximilien, et al.
Publicado: (2017)

Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy
por: McAdoo, Stephen, et al.
Publicado: (2018)

Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to Candida Species
por: Negoro, Paige E., et al.
Publicado: (2020)

Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2021)

Spleen Tyrosine Kinase Contributes to Müller Glial Expression of Proangiogenic Cytokines in Diabetes
por: Yerlikaya, Esma I., et al.
Publicado: (2022)

Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis
por: Stevens, Megan, et al.
Publicado: (2019)

Cryptotanshinone inhibits IgE-mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine-protein kinase phosphorylation in mast cells
por: Buyanravjikh, Sumiyasuren, et al.
Publicado: (2021)

A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation
por: Ferguson, Gregory D., et al.
Publicado: (2016)

Alternative Splicing and Tumor Progression
por: Ghigna, Claudia, et al.
Publicado: (2008)

Pharmacokinetics and Efficacy of the Spleen Tyrosine Kinase Inhibitor R406 after Ocular Delivery for Retinoblastoma
por: Pritchard, Eleanor M., et al.
Publicado: (2014)

Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer
por: Yu, Yu, et al.
Publicado: (2019)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in vivo
por: Frommhold, David, et al.
Publicado: (2007)

Spleen Tyrosine Kinase (Syk) Regulates Systemic Lupus Erythematosus (SLE) T Cell Signaling
por: Grammatikos, Alexandros P., et al.
Publicado: (2013)

Systematic Analysis of Spleen Tyrosine Kinase Expression and its Clinical Outcomes in Various Cancers
por: Alwithenani, Akram I., et al.
Publicado: (2020)

Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway
por: Liu, Kang-Han, et al.
Publicado: (2019)

Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer
por: Snezhkina, Anastasiya Vladimirovna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_duir330kee4l85ng60ua2pko7c